Skip to main content
. 2021 Sep 20;12:722730. doi: 10.3389/fphar.2021.722730

FIGURE 7.

FIGURE 7

SHCGT regulated gut microbiome-related metabolites and short-chain fatty acids and reduced endotoxin levels. (A) Concentrations of short-chain fatty acids, including butyrate, isobutyrate, propionate, and valerate. SHCGT significantly increased the isobutyrate, propionate, and valerate levels in mice with DNCB-induced AD. (B) Change in plasma endotoxin levels. The endotoxin level was lower in the group with SHCGT-treated AD than in the sham and AD groups. *p < 0.05, **p < 0.01 vs. sham; # p < 0.05, ## p < 0.01 vs. AD. AD, atopic dermatitis; DNCB, 2,4-dinitrochlorobenzene; SHCGT, Sihocheonggan-Tang.